EP3795177
ÓNÆMISVIÐTAKAR OG T-FRUMUVAKAEININGAR SEM ERU SÉRTÆKAR FYRIR CLAUDIN-18.2
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
9.5.2016EP published:
13.4.2022EP application number:
20193185.4
EP translation filed:
29.6.2022Grant published:
15.7.2022EPO information:
European Patent Register
Max expiry date:
8.5.2036Expiry date:
8.5.2026Next due date:
31.5.2026
Title in English:
CLAUDIN-18.2-SPECIFIC IMMUNORECEPTORS AND T CELL EPITOPESLanguage of the patent:
English
Timeline
Today
9.5.2016EP application
13.4.2022EP Publication
29.6.2022Translation submitted
15.7.2022Registration published
8.5.2026Expires
Owner
Name:
BioNTech Cell & Gene Therapies GmbHAddress:
An der Goldgrube 12, 55131 Mainz, DE
Name:
TRON - Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg- Universität Mainz gemeinnützige GmbHAddress:
Freiligrathstrasse 12, 55131 Mainz, DE
Inventor
Name:
SAHIN, UgurAddress:
55116 Mainz, DE
Name:
TÜRECI, ÖzlemAddress:
55116 Mainz, DE
Name:
SIMON, PetraAddress:
55129 Mainz, DE
Name:
OMOKOKO, TanaAddress:
55122 Mainz, DE
Name:
BREITKREUZ, AndreaAddress:
67551 Worms, DE
Name:
MROZ, Karolina AnnaAddress:
65195 Wiesbaden, DE
Name:
HEBICH, LisaAddress:
67304 Kerzenheim, DE
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
PCT/EP2015/060357Date:
11.5.2015Country:
WO
Classification
Categories:
A61K 39/395, C07K 14/725, C07K 7/06, C07K 14/47, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 27.6.2022
Expires: 8.5.2023
Payer: Patice ehf.
Number: 8
Paid: 22.4.2023
Expires: 8.5.2024
Payer: Árnason Faktor ehf.
Number: 9
Paid: 19.4.2024
Expires: 8.5.2025
Payer: Árnason Faktor ehf.
Number: 10
Paid: 9.5.2025
Expires: 8.5.2026
Payer: Árnason Faktor ehf.